BL
EW icon

Balentine LLC’s Edwards Lifesciences EW Stock Holding History

Balentine LLC’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,770
Closed -$1.12M – 307
2024
Q1 		$1.12M Buy
11,770
+6,937
+144% +$583K 0.03% 173
2023
Q4 		$369K Buy
+4,833
New +$336K 0.01% 349
2023
Q3 		– Sell
-4,317
Closed -$407K – 574
2023
Q2 		$407K Buy
4,317
+1,173
+37% +$102K 0.01% 313
2023
Q1 		$260K Buy
+3,144
New +$247K 0.01% 456
2022
Q4 		– Sell
-4,816
Closed -$398K – 660
2022
Q3 		$398K Buy
4,816
+1,123
+30% +$108K 0.02% 331
2022
Q2 		$351K Sell
3,693
-810
-18% -$83.9K 0.01% 394
2022
Q1 		$530K Buy
4,503
+1,986
+79% +$223K 0.02% 282
2021
Q4 		$326K Buy
2,517
+461
+22% +$53.8K 0.01% 238
2021
Q3 		$233K Buy
+2,056
New +$235K 0.01% 217
2020
Q3 		– Sell
-576
Closed -$40K – 388
2020
Q2 		$40K Buy
576
+72
+14% +$5.12K ﹤0.01% 274
2020
Q1 		$32K Sell
504
-624
-55% -$45K ﹤0.01% 221
2019
Q4 		$88K Buy
1,128
+600
+114% +$46.9K ﹤0.01% 130
2019
Q3 		$39K Buy
528
+66
+14% +$4.64K ﹤0.01% 156
2019
Q2 		$28K Buy
462
+78
+20% +$4.72K ﹤0.01% 172
2019
Q1 		$24K Hold
384
– – ﹤0.01% 190
2018
Q4 		$20K Hold
384
– – ﹤0.01% 190
2018
Q3 		$22K Buy
+384
New +$18.8K ﹤0.01% 131
2018
Q1 		– Sell
-3,705
Closed -$139K – 215
2017
Q4 		$139K Buy
3,705
+870
+31% +$31.9K 0.01% 160
2017
Q3 		$103K Buy
2,835
+1,245
+78% +$47.5K 0.01% 182
2017
Q2 		$63K Sell
1,590
-741
-32% -$27K 0.01% 216
2017
Q1 		$73K Buy
2,331
+2,079
+825% +$65.1K 0.01% 191
2016
Q4 		$8K Buy
252
+54
+27% +$1.75K ﹤0.01% 423
2016
Q3 		$8K Hold
198
– – ﹤0.01% 377
2016
Q2 		$7K Buy
+198
New +$6.77K ﹤0.01% 382

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Balentine LLC's EW Position: Q2 2024 in Review

Balentine LLC sold out of Edwards Lifesciences (EW) in Q2 2024, closing a stake of 11,770 shares — an estimated $1.12M sold.

Balentine LLC first reported a position in EW in Q2 2016 and held it in 24 quarters. The position peaked at $1.12M in Q1 2024. 1,297 funds tracked by Wall St. Rank hold EW as of Q2 2024.

  • Balentine LLC reported no remaining Edwards Lifesciences position as of Q2 2024 after selling out during the quarter.
  • Balentine LLC sold 11,770 Edwards Lifesciences shares in Q2 2024, an estimated $1.12M.
  • Balentine LLC first reported a position in Edwards Lifesciences in Q2 2016 and held it in 24 quarters.
  • Balentine LLC's Edwards Lifesciences position peaked at $1.12M in Q1 2024.
  • 1,297 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2024.

Based on Balentine LLC's 13F filing for Q2 2024, filed 7 Aug 2024.